D.A. Davidson & Co’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$804K Sell
9,689
-400
-4% -$33.2K 0.01% 873
2025
Q1
$818K Sell
10,089
-185
-2% -$15K 0.01% 843
2024
Q4
$925K Sell
10,274
-150
-1% -$13.5K 0.01% 802
2024
Q3
$1.03M Sell
10,424
-20,024
-66% -$1.98M 0.01% 760
2024
Q2
$2.82M Sell
30,448
-11,914
-28% -$1.1M 0.03% 442
2024
Q1
$4.02M Buy
42,362
+30,197
+248% +$2.87M 0.04% 345
2023
Q4
$1.09M Sell
12,165
-2,012
-14% -$180K 0.01% 688
2023
Q3
$1.04M Sell
14,177
-712
-5% -$52K 0.01% 674
2023
Q2
$1.24M Sell
14,889
-27
-0.2% -$2.25K 0.01% 623
2023
Q1
$1.14M Buy
14,916
+1,105
+8% +$84.2K 0.01% 628
2022
Q4
$1.15M Buy
13,811
+410
+3% +$34K 0.01% 587
2022
Q3
$1.06M Buy
13,401
+1,289
+11% +$102K 0.01% 571
2022
Q2
$900K Buy
12,112
+894
+8% +$66.4K 0.01% 629
2022
Q1
$1.01M Buy
11,218
+806
+8% +$72.4K 0.01% 652
2021
Q4
$1.17M Buy
10,412
+886
+9% +$99.2K 0.01% 607
2021
Q3
$1.2M Buy
9,526
+491
+5% +$61.7K 0.01% 575
2021
Q2
$1.22M Sell
9,035
-1,867
-17% -$253K 0.01% 571
2021
Q1
$1.48M Buy
10,902
+2,277
+26% +$309K 0.02% 474
2020
Q4
$1.21M Buy
8,625
+148
+2% +$20.8K 0.02% 462
2020
Q3
$945K Buy
8,477
+203
+2% +$22.6K 0.02% 462
2020
Q2
$926K Buy
8,274
+4,113
+99% +$460K 0.02% 459
2020
Q1
$322K Buy
4,161
+151
+4% +$11.7K 0.01% 712
2019
Q4
$381K Buy
4,010
+209
+5% +$19.9K 0.01% 751
2019
Q3
$290K Sell
3,801
-10
-0.3% -$763 0.01% 795
2019
Q2
$334K Sell
3,811
-35
-0.9% -$3.07K 0.01% 744
2019
Q1
$348K Sell
3,846
-50
-1% -$4.52K 0.01% 807
2018
Q4
$280K Sell
3,896
-80
-2% -$5.75K 0.01% 843
2018
Q3
$381K Buy
3,976
+86
+2% +$8.24K 0.01% 815
2018
Q2
$370K Buy
3,890
+115
+3% +$10.9K 0.01% 803
2018
Q1
$331K Sell
3,775
-380
-9% -$33.3K 0.01% 832
2017
Q4
$353K Sell
4,155
-275
-6% -$23.4K 0.01% 779
2017
Q3
$383K Hold
4,430
0.01% 753
2017
Q2
$341K Buy
4,430
+1,000
+29% +$77K 0.01% 738
2017
Q1
$237K Buy
3,430
+75
+2% +$5.18K 0.01% 868
2016
Q4
$198K Buy
+3,355
New +$198K ﹤0.01% 1010